Jaguar Health, Inc. (JAGX) Operating margin 2016–2025
Jaguar Health, Inc. (JAGX) operating margin by fiscal year — reported operating income divided by reported revenue.
-398.8%FY2025 · since FY2016: -9599.8% → -398.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -398.8% | -135.1 pp |
| FY2024 | -263.8% | +87.5 pp |
| FY2023 | -351.3% | -63.5 pp |
| FY2022 | -287.8% | +651.2 pp |
| FY2021 | -939.1% | -655.1 pp |
| FY2020 | -283.9% | +217.3 pp |
| FY2019 | -501.3% | +196.7 pp |
| FY2018 | -698.0% | +87.3 pp |
| FY2017 | -785.3% | +8814.6 pp |
| FY2016 | -9599.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More JAGX financial trends
JAGX RevenueJAGX Net incomeJAGX Net marginJAGX Gross profitJAGX Gross marginJAGX Operating incomeJAGX Operating cash flowJAGX Free cash flowJAGX Capital expendituresJAGX Return on equityJAGX Stock buybacksJAGX Dividends paidJAGX Total assetsJAGX Total liabilitiesJAGX Shareholders’ equityJAGX overview →